Logo - RBT.jpg
Renibus Therapeutics’ COVID-19 Treatment, RBT-9, Shows Antiviral Activity Against SARS-CoV-2 In Vitro
October 07, 2020 09:00 ET | Rénibus Therapeutics Inc.
DALLAS, Texas, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that its investigational treatment for COVID-19, RBT-9, has...
Vielight Commences Recruitment for COVID-19 Clinical Trial in Ontario
September 10, 2020 09:00 ET | Vielight Inc.
Toronto, Canada, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Vielight Inc. is pleased to announce the commencement of recruitment for a COVID-19 clinical trial in Ontario, Canada. This involves a home-use...
Vielight Launches COVID-19 Clinical Trial with Home-Use Device
September 01, 2020 09:00 ET | Vielight Inc.
Toronto, Canada, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Vielight Inc. is pleased to announce the commencement of a new clinical trial in the USA. In this trial, Vielight Inc. will test the hypothesis...
synairgen.png
Synairgen Completes Recruitment of Hospitalised Patients in COVID-19 Trial
May 28, 2020 07:00 ET | Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen Completes Recruitment of Hospitalised Patients in COVID-19 Trial Southampton, UK – 28 May 2020: Synairgen plc (LSE: SNG), the...